A correlation between the presence of 5.6-kilobase plasmids and bacteriocin activity was found in human-derived strains of Streptococcus mutans. Compared with bacteriocin activity of randomly selected clinical isolates of plasmid-negative strains, bacteriocin activity of plasmid-positive straiis significantly inhibited not only two laboratory strains of S. mutans, OMZ176 and AHT (P < 0.0001 and P = 0.038, respectively), but most plasmid-negative clinical isolates as well (P = 0.0005). Comparisons of inhibition between pairs of plasmid-positive strains revealed two groups, group I and group II, that produced distinct bacteriocins we designated as mutacin I and mutacin II, respectively. Within each group, a strain produced inhibitory activity against all the members of the other group but against no members of its own group. Plasmid DNA from plasmid-positive strains of each group was isolated and analyzed by restriction endonuclease digestion. Plasmids from the two groups that were apparently identical in size differed in digestion patterns for EcoRI, HaeIII, and TaqI, even though six TaqI fragments appeared to be common to all. Based on bacteriocin profiles and restriction enzyme digests, two distinct groups of plasmid-positive S. mutans strains emerged.
Although the bacteriocin activity of plasmid-positive strain LM7 (serotype e) placed it in group I, clear differences in restriction digests distinguished it from the other plasmid-containing strains.
Plasmids are found in virtually every species of the genus Streptococcus and mediate a wide variety of biological activities, including antibiotic or heavy-metal resistance, bateriocin production and immunity, and various sexual functions (4) . Other streptococcal plasmids have unknown functions and are designated cryptic. These include the 5.6-kilobase (kb) plasmid found within strains of the species Streptococcus mutans and first described in 1973 (7) . A plasmid (or plasmids) having this size appears in S. mutans isolated from clinical populations at a prevalence of 5 to 13% (3, 14) . With the exception of the serotype e strain LM7, all known plasmid-containing strains of S. mutans isolated from humans are biotype I (serotypes cl) (3, 13, 14) . Accordingly, the observations that plasmids isolated from human-derived S. mutans appear identical in size, are almost exclusively of one biotype, and exhibit similarities in restriction enzyme patterns suggested that a single disseminated plasmid was common to all strains (13, 14) .
Previously, we used plasmid DNA as an epidemiological marker for denoting homology of S. mutans strains within families (3) . In addition, we investigated several bacteriocintyping methods (2, 8, 11) , also used for ascertaining homology of strains. In doing this, we observed a relationship between the presence of plasmids and bacteriocin activity.
( The 15 plasmid-positive clinical isolates and strains LM7 and V318 were further tested for bacteriocin-like activity among themselves. Each of the 17 plasmid-positive strains was used both as producer and as indicator.
Preliminary characterization of bacteriocin-like activity. Sensitivity to pronase and trypsin of zones of inhibition produced by the bacteriocin-like substance of plasmid-positive strains was tested as previously described (8) . Strain OMZ176 was used as the indicator.
Four plasmid-positive strains were tested for formation of bacteriophage-like plaques as a test of infectivity by the method described by Berkowitz and Jordan (2) .
Seven plasmid-positive and two plasmid-negative clinical S. mutans strains were used as producers in a modification of the UV induction technique described by Hamada and Ooshima (8 8 .0), pelleted by centrifugation, suspended in 5 ml of 25% glucose in TE buffer-1.25 ml of lysozyme solution (6 mg/ml in TE buffer), and incubated for 2 h at 37°C. A protease solution (proteinase K, type XI; Sigma) (6 mg/ml in TE buffer; preincubated for 1 h at 37°C) was then added, and incubation continued for another 30 min. After the addition of 5 ml of 20% sodium dodecyl sulfate in TE buffer and 20 min of incubation at room temperature, a series of separate solutions were added and mixed with gentle inversion: (i) 1 ml of freshly made 3 N NaOH; (ii) 2 ml of 2 M Tris (pH 7.0); and (iii) 6.5 ml of 5 M NaCl. After overnight refrigeration at 4°C, the supernatant obtained by centrifugation at 17,300 x g for 30 min in a Sorvall SS34 rotor was mixed with 2 parts absolute ethanol and 0.1 part 2 M sodium acetate (pH 5.3). DNA was precipitated by incubation overnight at -20°C or for 15 min in a dry ice-ethanol bath and then centrifugation for 15 min in a Sorvall SS34 rotor. After the precipitate was dissolved in 5 ml of TE buffer, plasmid DNA was purified by one or two cycles of CsCl-ethidium bromide density equilibrium centrifugation (6) .
Restriction enzymes. The restriction endonucleases HindIll, EcoRI, HaeIII, PstI, and TaqI were obtained from Bethesda Research Laboratories, Inc., Gaithersburg, Md., and used with buffers as described previously (6) . All endonuclease digestions were for 30 min at 37°C, except for PstI (30°C) and TaqI (65°C).
Agarose and agarose-acrylamide gel electrophoresis. The products of endonuclease digestion were electrophoresed on 0.7% agarose horizontal slab gels or agarose-acrylamide vertical slab gels (2% acrylamide, 0.1% bisacrylamide, 0.7% agarose) (10) . The running buffer was 40 mM Tris hydrochloride-5 mM sodium acetate-1 mM EDTA, adjusted to pH 7.6 with acetic acid. For loading, DNA was mixed with 0.2 volume of 50% glycerol-0.15% bromophenol blue-0.5% sodium dodecyl sulfate; with agarose-acrylamide gels, the sodium dodecyl sulfate was omitted. After electrophoresis, gels were stained in a solution of 2 ,ug of ethidium bromide Molecular weight standards for supercoiled plasmid DNA were plasmids from Escherichia coli V517 (12) . Molecular weight standards for linear DNA fragments were bacteriophage lambda DNA digested with HindIll or doublestranded 4X174 DNA digested with HaeIII (Bethesda Research Laboratories). Standard curves were drawn as plots of molecular weight versus relative mobility.
RESULTS
Plasmid-containing strains of S. mutans. Extending our previous work (3), we found a plasmid similar in size to the 5.64-kb (3.6-megadalton) plasmid described by Macrina et al. (13, 14) in 26 of 315 children screened (8% prevalence of plasmid-containing strains). All of the plasmid-positive and 98% of the plasmid-negative S. mutans clinical isolates were biotype I (serotype c/J). We selected 15 plasmid-positive strains for further study. For reference, we also included two laboratory strains with partially characterized 5.6-kb plasmids: LM7 (serotype e) and V318 (serotype c) (1, 7, 9, 13, 14) .
Inhibition of representative serotypes of S. mutans laboratory strains by plasmid-positive strains. We examined bacteriocin-like properties of both plasmid-positive and plasmid-negative strains against six different indicator strains representing S. mutans serotypes a, b, c, d, e, and g (Table  1 ). Only two strains showed statistically significant differences between patterns of inhibition produced by plasmidpositive and plasmid-negative strains. Of 17 plasmid-positive strains (including strains LM7 and VA318), 15 produced zones of inhibition against S. mutans OMZ176; none of 18 plasmid-negative strains tested inhibited this strain (Table 2) . A typical stab plate showing positively scored zones of inhibition against OMZ176 is shown in Fig. 1 . Relative frequencies of inhibition versus noninhibition revealed a statistically significant relationship (P < 0.0001, Fisher Exact test) between the presence of the plasmid and zones of inhibition against indicator strain OMZ176. Although strain AHT showed a significant association between zones of inhibition and presence of a plasmid (P = 0.038), OMZ176 was more selective and therefore was used in subsequent experiments.
Susceptibility of plasmid-negative and plasmid-positive clinical isolates to bacteriocins produced by plasmid-positive strains. The 17 plasmid-positive strains were next tested for their ability to produce inhibitory zones against randomly selected plasmid-negative clinical isolates (Table 3) . Plasmidpositive strains of S. mutans inhibited plasmid-negative strains in 76% of all possible tests of pairs, whereas plasmidnegative strains used as producers showed inhibition in only 12% of the tests. The difference between these frequencies was significant (P = 0.0005, Sign test).
Although all 17 plasmid-positive strains tested contained a 5.6-kb plasmid and 15 of 17 produced zones of inhibition against indicator strain OMZ176, we found that when they were tested for inhibitory action against each other, the 17 strains could be divided into two distinct groups: 7 strains (including LM7) inhibited the remaining 10 strains (including V318). Conversely, these 10 strains when tested as producers inhibited the remaining 7 strains. None of the 7 strains in the first group or the 10 strains in the second group inhibited members within its own group. On the basis of these patterns of inhibition, we designated the seven strains that included LM7 as group I and the 10 strains that included V318 as group II.
Properties of bacteriocins from group 1 and 2 plasmid-positive strains. The effects of various treatments on zones of inhibition against strain OMZ176 were tested. Solid agar was used because inhibitory activity against sensitive strains of S. mutans was not apparent in liquid cultures.
Results with buffered media indicated that the zones of inhibition were not caused by acid production as measured by pH; the indicator strain OMZ176 grew equally well outside the zones on all the buffered plates, and intact zones of equal size were present on media buffered to pH 7.0, 6.5, and 6.0. (Zones were markedly reduced in size, however, on media buffered to pH 8.0.) Inhibitory zones were not caused by hydrogen peroxide since inhibitory activity was expressed in an anaerobic environment. Zones of inhibition were markedly reduced or eliminated, however, by incubation with trypsin or pronase. Inhibitory activity was not inducible with either UV light or mitomycin C, and excised zones of inhibition were not infective when placed on lawns (14) . We isolated the plasmid DNA of three plasmid-positive strains from each of the two bacteriocin groups. Strains from group I included LM7, UA37, and UA140. Strains from group II included V318, UA109, and UA405 (Table 1) . Digestion of plasmids from both groups with the restriction endonuclease Hindlll, PstI, or HpaI yielded one, one, or two fragments, respectively, similar to data previously reported (1, 9, 14) . However, restriction endonuclease digestion with EcoRI, HaeIII, and TaqI revealed differences between the plasmids of group I and group II strains. Hereafter, we will refer to plasmids from the two groups as group I and group II plasmids.
EcoRI cut each group I plasmid (pLM7 once; pUA37 and pUA140 twice) (Fig. 2, lanes D through F) but cut no group 2 plasmid (lanes G through I). Controls of undigested plasmids pLM7 and pVA318 are shown in lanes B and C. HaeIII cut each group II plasmid once (Fig. 3 , lanes E through G) but did not cleave group I plasmids pUA37 and pUA140 (lanes C and D). The other group I plasmid, pLM7, was cut twice; one fragment was almost full-sized (Fig. 3, lane B) . The second, 270-base-pair fragment was seen by agarosepolyacrylamide gel electrophoresis (data not shown).
After TaqI digestion, all three group II plasmids had identical patterns of eight fragments each (Fig. 4a , lanes E through G). Two group I plasmids had identical patterns showing 10 fragments, but pLM7 had one TaqI site fewer (lanes B through D). All plasmids in both groups had six TaqI fragments of identical size (Fig. 4a and b) .
In all restriction endonuclease digestion experiments, the sizes of the fragments resulting from endonuclease digestion were calculated by comparison with linear size standards. The sum of fragments from any individual digestion was within 5% of the expected 5.64-kb plasmid contour length as measured by Hansen et al. (9) .
Because the group I plasmid pLM7 differed from group I plasmids pUA37 and pUA140, we isolated plasmid DNA from two additional group I strains (UA174 and UA728). They showed TaqI, EcoRI, and HaeIII digestion patterns of fragments that were identical to those of both pUA37 and pUA140 (data not shown). (9, 13, 14) . This is likely due to the limited number of plasmid-positive strains available for testing as well as to differences in methods for demonstrating bacteriocin activity. For example, Macrina and co-workers (13) observed differences in bacteriocin-like in- Our results contrasted with those of some published work. We found more TaqI sites in the S. mutans 5.6-kb plasmids than previously reported (14) , as well as a difference between plasmids pLM7 and pVA318 not previously detected (14) . In our work, the sum of all the TaqI fragments from any individual digestion was always within 5% of the size of the entire plasmid, and the patterns were repeatable (data not shown). Thus, we evidently obtained complete digests (which may include some yet-undetected fragments smaller than 270 base pairs).
Restriction endonuclease data suggested that plasmids of groups I and II were at least 70% homologous (based on the sum sizes of the six apparently common TaqI fragments). Our present working hypothesis is that the regions of the plasmids responsible for the observed restriction fragment length polymorphisms are also involved with bacteriocin production or immunity, or both. We conclude that instead of a single disseminated plasmid among strains of S. mutans as originally proposed (14) , there appear to be at least two distinct, although related, disseminated 5.6-kb plasmids in S. In addition, we thank Gary Cutter for his valuable assistance in the statistical analysis of the data and Roy Curtiss for guidance and critical review of this manuscript.
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